R. Biagini

Research interests

Publications

• Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

  Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2021.07.006

• Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts

  ESMO Open · 2021 · 10.1016/j.esmoop.2021.100170

• Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2021.09.005

• Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up

  Annals of Oncology · 2021 · 10.1016/j.annonc.2021.08.1995

• Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy095

• Corrections to “Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up”

  Annals of Oncology · 2018 · 10.1093/annonc/mdy320

• Corrections to “Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up”

  Annals of Oncology · 2018 · 10.1093/annonc/mdy321

• Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy096

• Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy310

• Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial

  The Lancet Oncology · 2014 · 10.1016/s1470-2045(14)71136-2

• Giant Cell Tumor of the Mobile Spine

  Spine · 2011 · 10.1097/brs.0b013e3182233ccd

• Spinal Instability Neoplastic Score: An Analysis of Reliability and Validity From the Spine Oncology Study Group

  Journal of Clinical Oncology · 2011 · 10.1200/jco.2010.34.3897

• Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients

  BMC Cancer · 2010 · 10.1186/1471-2407-10-22

• A Novel Classification System for Spinal Instability in Neoplastic Disease

  Spine · 2010 · 10.1097/brs.0b013e3181e16ae2

• Chordoma of the Mobile Spine: Fifty Years of Experience

  Spine · 2006 · 10.1097/01.brs.0000200038.30869.27

• Neoadjuvant chemotherapy for high‐grade central osteosarcoma of the extremity

  Cancer · 2003 · 10.1002/cncr.11456

• Aneurysmal Bone Cyst of the Mobile Spine

  Spine · 2001 · 10.1097/00007632-200101010-00007

• Chondrosarcoma of the Mobile Spine

  Spine · 2000 · 10.1097/00007632-200004010-00008

• Primary Bone Tumors of the Spine

  Spine · 1997 · 10.1097/00007632-199705010-00020

• A System for Surgical Staging and Management of Spine Tumors

  Spine · 1997 · 10.1097/00007632-199708010-00018

• Chordoma of the Spine Above the Sacrum

  Spine · 1996 · 10.1097/00007632-199607010-00017

• En Bloc Resections of Bone Tumors of the Thoracolumbar Spine

  Spine · 1996 · 10.1097/00007632-199608150-00020

• Stimulatory effect on bone formation exerted by a modified chitosan

  Biomaterials · 1994 · 10.1016/0142-9612(94)90093-0

• Selective arterial embolization in the treatment of aneurysmal bone cyst and angioma of bone

  Skeletal Radiology · 1992 · 10.1007/bf00195235

• Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities the istituto rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin

  Cancer · 1990 · 10.1002/1097-0142(19900601)65:11<2539::aid-cncr2820651125>3.0.co;2-m

Current projects

No projects listed.